TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22552615

Group type: EXPERIMENTAL
Intervention: Transportal technique (TP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Outside-in technique (OI)
Number of subjects: 80
Study: 21197542

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO(3))
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (CaCO(3))
Number of subjects: 11
Study: 19281499

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation plus conventional medical management (CMM), n = 52
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional medical management (CMM) alone, n = 48
Number of subjects: 100
Study: 17237134

Group type: EXPERIMENTAL
Intervention: Carvedilol (up to 25 mg twice a day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 14963054

Group type: EXPERIMENTAL
Intervention: Low-soluble fiber diet (0.4 g added soluble fiber/2800 kcal)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Medium-soluble fiber diet (3 g added soluble fiber/2800 kcal)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-soluble fiber diet (6 g added soluble fiber/2800 kcal)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: All experimental diets
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-soluble fiber diet
Number of subjects: 18
Study: 11758955

Group type: EXPERIMENTAL
Intervention: Tc‐99m‐ECD SPECT
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal controls (NC group)
Number of subjects: 12
Study: 8979210

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Coping Skills Therapy
Number of subjects: 1726

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy
Number of subjects: 1726

Group type: EXPERIMENTAL
Intervention: Twelve-Step Facilitation Therapy
Number of subjects: 1726

Group type: EXPERIMENTAL
Intervention: 12-step facilitation treatment
Number of subjects: 1726

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy
Number of subjects: 1726
Study: 8424548

Group type: EXPERIMENTAL
Intervention: 1 mg ondansetron
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: 4 mg ondansetron
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: 8 mg ondansetron
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study: 3662056

Group type: EXPERIMENTAL
Intervention: naloxone 0.08 mg IV every 2 min
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: nalbuphine 2.5 mg IV every 2 min
Number of subjects: 90
Study: 29530258

Group type: EXPERIMENTAL
Intervention: Self-guided CBT via the Internet (ICBT)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Group CBT
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 92
Study: 26620919

Group type: EXPERIMENTAL
Intervention: Recombinant antithrombin
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 25541821

Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Azithromycin: 500 mg once per day for 3 days + standard medical care
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Azithromycin: 500 mg once per day for 7 days, followed by 500 mg once per week for 12 weeks + standard medical care
Number of subjects: 60
Study: 22823289

Group type: EXPERIMENTAL
Intervention: Multigroup item randomized response theory (MIRRT)
Number of subjects: 6195

Group type: EXPERIMENTAL
Intervention: MIRRT
Number of subjects: 6195
Study: 20081092

Group type: COMPARATOR
Intervention: Urinary hepcidin (nanograms/milligram of urinary creatinine) in patients with iron deficiency and inflammation anemia
Number of subjects: 582

Group type: COMPARATOR
Intervention: Urinary hepcidin
Number of subjects: 582

Group type: COMPARATOR
Intervention: IL-6 and CRP levels
Number of subjects: 582

Group type: COMPARATOR
Intervention: Proinflammatory markers (IL-6, CRP)
Number of subjects: 582
Study: 18855352

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 139

Group type: COMPARATOR
Intervention: Simvastatin/Pravastatin
Number of subjects: 139
Study: 15823180

Group type: EXPERIMENTAL
Intervention: Calf muscle energy metabolism in COPD patients
Number of subjects: 8

Group type: COMPARATOR
Intervention: Calf muscle energy metabolism in control subjects
Number of subjects: 8
Study: 12435217

Group type: EXPERIMENTAL
Intervention: Soy products
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Isoflavone preparations
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Black cohosh
Number of subjects: 29

Group type: COMPARATOR
Intervention: Dong quai
Number of subjects: 29

Group type: COMPARATOR
Intervention: Evening primrose oil
Number of subjects: 29

Group type: COMPARATOR
Intervention: Chinese herb mixture
Number of subjects: 29

Group type: COMPARATOR
Intervention: Vitamin E
Number of subjects: 29

Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 29

Group type: COMPARATOR
Intervention: Red clover
Number of subjects: 29
Study: 10353369

Group type: EXPERIMENTAL
Intervention: Semantic working memory task
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Phonological working memory task
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Orthographic working memory task
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Working memory tasks (semantic, phonological, orthographic)
Number of subjects: 12
Study: 7867177

Group type: EXPERIMENTAL
Intervention: 0.4 mg/h GTN skin patch
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 20
Study: 1431365

Group type: EXPERIMENTAL
Intervention: Cefepime (CFPM)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Ceftazidime (CAZ)
Number of subjects: 170
Study: 3969339

Group type: EXPERIMENTAL
Intervention: 1.2 mL of ferrous sulfate (FeSO4) drops (about 3 mg of iron per kilogram per day) for 3 months
Number of subjects: 278

Group type: COMPARATOR
Intervention: Placebo (equal volume) for 3 months
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: 1.2 mL of ferrous sulfate (FeSO4) drops
Number of subjects: 278

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278
Study: 30669918

Group type: EXPERIMENTAL
Intervention: Finned stem (FS)
Number of subjects: 54

Group type: COMPARATOR
Intervention: I-beam block stem (IS)
Number of subjects: 54
Study: 28913896

Group type: EXPERIMENTAL
Intervention: Topical non-azole solution applied to one paw
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo applied to the other paw
Number of subjects: 18
Study: 24272062

Group type: EXPERIMENTAL
Intervention: Retroperitoneoscopic ureterolithotomy (RPLU)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Open mini-incision ureterolithotomy (MIOU)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both RPLU and MIOU
Number of subjects: 70
Study: 22124101

Group type: EXPERIMENTAL
Intervention: Carboplatin (AUC 5) plus Paclitaxel (175 mg/m2) plus Bevacizumab (15 mg/kg) (CPB)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Carboplatin (AUC 5) plus Paclitaxel (175 mg/m2) (CP)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Carboplatin plus Paclitaxel plus Bevacizumab (CPB) in patients with elevated serum lactate dehydrogenase
Number of subjects: 214

Group type: COMPARATOR
Intervention: Carboplatin plus Paclitaxel (CP) in patients with elevated serum lactate dehydrogenase
Number of subjects: 214
Study: 20808678

Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control
Number of subjects: 89
Study: 18254223

Group type: EXPERIMENTAL
Intervention: Longidase (3000 IU, 10 injections, once in 5 days)
Number of subjects: 0
Study: 16003037

Group type: EXPERIMENTAL
Intervention: Patellar bracing
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Home exercise program with patellar bracing
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Home exercise program
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Home exercise program with knee sleeve
Number of subjects: 136
Study: 12638810

Group type: EXPERIMENTAL
Intervention: Advance provision of oral contraceptives (20 clients)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard provision of oral contraceptives (280 clients)
Number of subjects: 300
Study: 9430262

Group type: EXPERIMENTAL
Intervention: Factor D (beta-carotene, alpha-tocopherol (vitamin E), and selenium)
Number of subjects: 29584

Group type: COMPARATOR
Intervention: Multivitamin/mineral supplement (in a parallel trial)
Number of subjects: 29584
Study: 8091822

Group type: EXPERIMENTAL
Intervention: Enoximone (0.75 mg/kg i.v.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enoximone (0.075 mg/kg i.v.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enoximone (oral administration over one week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gallopamil (Ca(++)-blocker)
Number of subjects: 0
Study: 2834943

Group type: EXPERIMENTAL
Intervention: Red kidney beans
Number of subjects: 6

Group type: COMPARATOR
Intervention: Bran cereal
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Repeated consumption (day 1 vs day 7)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance test
Number of subjects: 6
Study: 29878267

Group type: EXPERIMENTAL
Intervention: 1 mg folic acid
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: 1.13 mg l-5-MTHF
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study: 28915914

Group type: EXPERIMENTAL
Intervention: β‐TCP‐containing screw
Number of subjects: 80

Group type: COMPARATOR
Intervention: pure PLLA screw
Number of subjects: 80
Study: 26573847

Group type: EXPERIMENTAL
Intervention: Involuntary reflexive pelvic floor muscle training in addition to standard training
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard physiotherapy program
Number of subjects: 96
Study: 24070102

Group type: EXPERIMENTAL
Intervention: Booking orders for spectacles with subsequent delivery
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: On‐the‐spot fitting and dispensing of spectacles
Number of subjects: 21

Group type: COMPARATOR
Intervention: Issued only a prescription
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 21
Study: 21397769

Group type: EXPERIMENTAL
Intervention: Fenofibrate/pravastatin 160/40 mg FDC
Number of subjects: 291

Group type: COMPARATOR
Intervention: Simvastatin 20 mg
Number of subjects: 291
Study: 18988075

Group type: EXPERIMENTAL
Intervention: Smokers anticipating smoking-related pictures
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nonsmokers anticipating smoking-related pictures
Number of subjects: 24
Study: 17015867

Group type: EXPERIMENTAL
Intervention: Tadalafil (10 mg)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 14557148

Group type: EXPERIMENTAL
Intervention: Cognitive therapy (n = 28)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Self-help booklet (n = 28)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Repeated assessments (n = 29)
Number of subjects: 97
Study: 11095435

Group type: EXPERIMENTAL
Intervention: 100 mg androstenedione (ASD) three times daily
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 8623961

Group type: EXPERIMENTAL
Intervention: Ondansetron 0.15 mg/kg
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Ondansetron 0.075 mg/kg
Number of subjects: 136
Study: 1543677

Group type: EXPERIMENTAL
Intervention: 125 mg of terbinafine
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 250 mg of terbinafine
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 500 mg of terbinafine
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 750 mg of terbinafine
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: N-demethylated metabolite
Number of subjects: 4
Study: 3897535

Group type: EXPERIMENTAL
Intervention: Piroxicam 10-20 mg once daily
Number of subjects: 140

Group type: COMPARATOR
Intervention: Indomethacin 75-125 mg in divided doses
Number of subjects: 140
Study: 31079275

Group type: EXPERIMENTAL
Intervention: Prolonged-release melatonin mini-tablets (PedPRM; 2–5 mg)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 29282534

Group type: EXPERIMENTAL
Intervention: Computerized cognitive training (CCT) for 8 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study: 27613521

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Low-exposure everolimus
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: High-exposure everolimus
Number of subjects: 366
Study: 24695940

Group type: EXPERIMENTAL
Intervention: Transoral resection using microelectrodes
Number of subjects: 54
Study: 22699730

Group type: EXPERIMENTAL
Intervention: Educational program in nursing (educational meetings, home visits, telenursing, printed book)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 63
Study: 19995670

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) plus bupropion
Number of subjects: 61

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT) plus placebo
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 61
Study: 18565463

Group type: EXPERIMENTAL
Intervention: Interactive, computer‐tailored intervention delivered on a CD‐ROM
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Print‐delivered, computer‐tailored intervention
Number of subjects: 442

Group type: COMPARATOR
Intervention: Print‐delivered, generic information
Number of subjects: 442
Study: 15517433

Group type: EXPERIMENTAL
Intervention: Vitamin E (5000 mg per day)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 12029811

Group type: EXPERIMENTAL
Intervention: Volunteers who received incentives
Number of subjects: 7186

Group type: COMPARATOR
Intervention: Volunteers who received no incentives
Number of subjects: 7186

Group type: EXPERIMENTAL
Intervention: Male volunteers
Number of subjects: 7186

Group type: EXPERIMENTAL
Intervention: Female volunteers
Number of subjects: 7186
Study: 9889803

Group type: EXPERIMENTAL
Intervention: Laser ablation of eschar with a rapidly scanned continuous wave carbon dioxide laser system, average energy of 99.2 ± 5.7 W.
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control wound sharply excised and autografted.
Number of subjects: 21
Study: 7552480

Group type: EXPERIMENTAL
Intervention: Didanosine sachets (250 mg or 167 mg twice daily for at least 1 month)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Didanosine chewable/dispersible tablets (200 mg or 125 mg after conversion from sachets)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Low-dose ddI (sachets, 167 mg; tablets, 125 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: High-dose ddI (sachets, 250 mg; tablets, 200 mg)
Number of subjects: 15
Study: 2288826

Group type: EXPERIMENTAL
Intervention: Chlorpromazine (50 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Haloperidol (3 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sulpiride (400 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6109568

Group type: EXPERIMENTAL
Intervention: Halazepam (80 to 160 mg)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Clorazepate (15 to 30 mg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Halazepam vs Clorazepate
Number of subjects: 64
Study: 31714322

Group type: EXPERIMENTAL
Intervention: 0.2 mg/mL oxycodone plus 0.1% ropivacaine
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.1% ropivacaine
Number of subjects: 80
Study: 31800987

Group type: EXPERIMENTAL
Intervention: POEM
Number of subjects: 221

Group type: COMPARATOR
Intervention: LHM plus Dor's fundoplication
Number of subjects: 221
Study: 27006419

Group type: EXPERIMENTAL
Intervention: Dual-task training (balance activities with cognitive tasks)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Single-task training (balance activities alone)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both groups (dual-task and single-task)
Number of subjects: 47
Study: 25808188

Group type: EXPERIMENTAL
Intervention: Compression at myofascial trigger points (MTrPs)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Compression at non-trigger points (non-MTrP)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Effleurage massage (superficial massage)
Number of subjects: 63
Study: 23382637

Group type: EXPERIMENTAL
Intervention: 20 mL 40% wt/vol barium sulfate suspension before 3 mealtimes, 60 mL 60% diatrizoate meglumine diluted in 250 mL water after supper, and 10 mg bisacodyl enteric‐coated tablets 1 h before oral administration of 2 L PEG‐4000 electrolyte solution (Study Group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Identical treatment to Study Group A, but bisacodyl was given 1 h after oral PEG‐4000 (Study Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group managed using the same strategy as Study Group A, but without administration of bisacodyl
Number of subjects: 60
Study: 21372756

Group type: EXPERIMENTAL
Intervention: Belatacept (more intensive regimen)
Number of subjects: 1209

Group type: EXPERIMENTAL
Intervention: Belatacept (less intensive regimen)
Number of subjects: 1209

Group type: COMPARATOR
Intervention: Cyclosporine A (CsA)
Number of subjects: 1209
Study: 19214123

Group type: EXPERIMENTAL
Intervention: Saquinavir/ritonavir (SQV/r) 1000 mg/100 mg twice a day
Number of subjects: 337

Group type: COMPARATOR
Intervention: Lopinavir/ritonavir (LPV/r) 400 mg/100 mg twice a day
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Saquinavir/ritonavir (SQV/r)
Number of subjects: 337

Group type: COMPARATOR
Intervention: Lopinavir/ritonavir (LPV/r)
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Saquinavir/ritonavir (SQV/r) and Lopinavir/ritonavir (LPV/r)
Number of subjects: 337
Study: 17626759

Group type: EXPERIMENTAL
Intervention: Shenqi injection after operation
Number of subjects: 60

Group type: COMPARATOR
Intervention: No immune supportive treatment (Control)
Number of subjects: 60
Study: 15595909

Group type: EXPERIMENTAL
Intervention: Chronic disease management model of transitional care
Number of subjects: 166
Study: 11718454

Group type: EXPERIMENTAL
Intervention: Daily supplementation with beta-carotene (6 mg), vitamin E (30 mg), vitamin C (120 mg), selenium (100 microg), and zinc (20 mg) for 2 years
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study: 9428250

Group type: EXPERIMENTAL
Intervention: Magnetic-resonance pelvimetry (reported to obstetricians)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Control group (pelvimetry results not disclosed)
Number of subjects: 235
Study: 8483620

Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil (5 mg/kg twice daily for 10 days)
Number of subjects: 578

Group type: COMPARATOR
Intervention: Penicillin V (13.4 mg/kg three times daily for 10 days)
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil
Number of subjects: 578

Group type: COMPARATOR
Intervention: Penicillin V
Number of subjects: 578
Study: 3316538

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 269

Group type: COMPARATOR
Intervention: Strict controls
Number of subjects: 269

Group type: COMPARATOR
Intervention: All controls
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Treated subjects
Number of subjects: 269
Study: 28988159

Group type: EXPERIMENTAL
Intervention: CC+SI
Number of subjects: 2

Group type: COMPARATOR
Intervention: 3:1 C:V
Number of subjects: 2
Study: 26505570

Group type: EXPERIMENTAL
Intervention: Ropivacaine (10 mL, 75 mg)
Number of subjects: 163
Study: 25391305

Group type: EXPERIMENTAL
Intervention: B-vitamin group (400 µg folic acid and 500 µg vitamin B12 daily)
Number of subjects: 2919

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 2919
Study: 22285894

Group type: EXPERIMENTAL
Intervention: Dual-task Switch Exercise (DSE)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (steady-state walking training)
Number of subjects: 18
Study: 20861296

Group type: EXPERIMENTAL
Intervention: SGRQ-I (IPF-specific version of the St George's Respiratory Questionnaire)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: SGRQ-I
Number of subjects: 158

Group type: COMPARATOR
Intervention: Original SGRQ
Number of subjects: 158
Study: 18795524

Group type: EXPERIMENTAL
Intervention: White ProRoot Mineral Trioxide Aggregate (WMTA)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Calcium Hydroxide (CH)
Number of subjects: 48
Study: 15904552

Group type: EXPERIMENTAL
Intervention: Educational intervention on intercultural communication for GPs and patients, including training on cultural differences and a videotaped instruction for patients on communication.
Number of subjects: 2407

Group type: EXPERIMENTAL
Intervention: Educational intervention on intercultural communication for GPs and patients.
Number of subjects: 2407
Study: 12888775

Group type: EXPERIMENTAL
Intervention: 600 mg of encapsulated dried leaf
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1000 mg of encapsulated dried leaf
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1600 mg of encapsulated dried leaf
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 10598599

Group type: EXPERIMENTAL
Intervention: Controlled hyperventilation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Spontaneous breathing
Number of subjects: 30
Study: 7862473

Group type: EXPERIMENTAL
Intervention: Aqueous nasal beclomethasone (336 micrograms/day)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Aqueous nasal beclomethasone (168 micrograms/day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Aqueous nasal beclomethasone
Number of subjects: 17
Study: 1945637

Group type: EXPERIMENTAL
Intervention: Sugar
Number of subjects: 26

Group type: COMPARATOR
Intervention: Saccharin
Number of subjects: 26

Group type: COMPARATOR
Intervention: Aspartame
Number of subjects: 26
Study: 7039940

Group type: EXPERIMENTAL
Intervention: melphalan (M)
Number of subjects: 38

Group type: COMPARATOR
Intervention: CAF (adriamycin, 5-fluorouracil and cyclophosphamide)
Number of subjects: 38
Study: 30846665

Group type: EXPERIMENTAL
Intervention: Carbon monoxide measurement feedback and standard brief motivation
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard brief motivational strategy
Number of subjects: 160